SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Human Genome Sciences, Inc. (HGSI)
An SI Board Since March 1996
Posts SubjectMarks Bans Symbol
1127 105 0 HGSI
Emcee:  Jeffrey Ogbar Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1027Human Genome Sciences Announces $40 Million Milestone Payment Related to Albufernigel bates-8/28/2007
1026ASPV Sinks to 12-Month Low on CellCept Results in Lupus: investorshub.comDewDiligence_on_SI-6/27/2007
1025June 25, 2007 - - j. birchenough Human Genome Sciences (HGSI - US$ 9.76) 2-Equasoftware salesperson-6/26/2007
1024sold 1/2 my hgsi last week after steve's excellent post. sold the rest todaybob zagorin-6/26/2007
1023meanwhile....(can someone smarter than me explain if and how this is relevant tobob zagorin-6/14/2007
1022and the short story... Human Genome's Drug Shows Lupus Activity Thursday Jubob zagorin-6/14/2007
1021Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B(R) Showed Sigbob zagorin-6/14/2007
1020for comparison, GSCO brief on Idenix results... Idenix Pharmaceuticals, Inc. EPbob zagorin-6/14/2007
1019FMR still owns almost 10% xml.10kwizard.combob zagorin-6/11/2007
1018<i>In yesterday's brief slide show, Watson showed and talked about a sDewDiligence_on_SI-6/8/2007
1017Dew, I'm with you there. In yesterday's brief slide show, Watson showedSteven Rachbach-6/8/2007
1016A reasonable assumption based on the Albuferon data to date: NVS is going to havDewDiligence_on_SI-6/8/2007
1015Scott, That's a really good point about the higher QOL for Albuferon but thSteven Rachbach-6/8/2007
1014Once on treatment, patients look after injections themselves at home, similarFishfinder-6/8/2007
1013Hepatitis C drug tests encouraging to HGS By Tricia Bishop sun reporter Originalbob zagorin-6/8/2007
1012have a great trip. thanks for your insight...bob zagorin-6/8/2007
1011At today’s Bear Stearns Conference, Tom Watkins, CEO, gave a 3 minute overview Steven Rachbach-6/8/2007
1010I will use the dreaded device of the sports analogy to drive home some points anSteven Rachbach-6/7/2007
1009dj just ran a headline saying hgsi and partner mulling higher dosing but no textbob zagorin-6/7/2007
1008Isn't dosing once or twice monthly a major advantage over weekly dosing? GoIan@SI-6/7/2007
1007GSCO notes some of your concerns steve but is a little more positive in this updbob zagorin-6/7/2007
1006I have studied today’s PR and have looked through old PRs and slide shows concerSteven Rachbach-6/7/2007
1005Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at bob zagorin-6/7/2007
1004Human Genome Sciences Announces Positive Final Results Of Phase 2b Trial of Albubob zagorin-6/7/2007
1003Tuck, There was a series of discussions about this in late April/early May. BelSteven Rachbach-6/6/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News